Global Over-the-counter (OTC) Drug Market 2024-2028

Over-the-counter (OTC) Drug Market 2024-2028

The over-the-counter (OTC) drug market is forecasted to grow by USD 56.1 bn during 2023-2028, accelerating at a CAGR of 6% during the forecast period. The report on the over-the-counter (OTC) drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by new product launches in global over-the-counter drug market, rising prevalence of diseases and OTC drug use, and favorable regulatory framework for OTC drugs.

Technavio's over-the-counter (OTC) drug market is segmented as below:

• By Distribution Channel
• Offline
• Online
• By Route Of Administration
• Oral
• Topical
• Parenteral
• Others
• By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing number of geriatric population as one of the prime reasons driving the over-the-counter (OTC) drug market growth during the next few years. Also, increasing healthcare expenditure and growing adoption of e-commerce platform for OTC drugs will lead to sizable demand in the market.

The report on the over-the-counter (OTC) drug market covers the following areas:

• Over-the-counter (OTC) drug market sizing
• Over-the-counter (OTC) drug market forecast
• Over-the-counter (OTC) drug market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over-the-counter (OTC) drug market vendors that include Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Inc., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.. Also, the over-the-counter (OTC) drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.